» Authors » Martina Willhauck-Fleckenstein

Martina Willhauck-Fleckenstein

Explore the profile of Martina Willhauck-Fleckenstein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 531
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahman S, Wathington D, Waterboer T, Pawlita M, Villa L, Lazcano-Ponce E, et al.
PLoS One . 2021 Jun; 16(6):e0253005. PMID: 34157055
Objectives: To estimate the seroprevalence of Chlamydia trachomatis (CT), herpes simplex type-2 (HSV2), hepatitis C (HCV), Epstein-Barr virus (EBV) and nine human papilloma virus (HPV) types, and investigated factors associated...
2.
Ben-Eli H, Solomon A, Aframian D, Ben-Chetrit E, Mevorach D, Kleinstern G, et al.
PLoS One . 2020 Dec; 15(12):e0244712. PMID: 33382786
Objectives: To compare hematologic and serological parameters among patients with Sjogren's syndrome (SS), dry eye syndrome (DES) and controls, and validate a novel multiplex-serology method for identifying auto-antibodies in these...
3.
Pattyn J, Panicker G, Willhauck-Fleckenstein M, Van Keer S, Teblick L, Pieters Z, et al.
J Med Virol . 2020 Apr; 92(12):3774-3783. PMID: 32266996
Vaccine-induced human papillomavirus (HPV) antibodies originating from cervicovaginal secretions were recently shown to be detectable in first-void (FV) urine. This presents a novel opportunity for noninvasive sampling to monitor HPV...
4.
Van Keer S, Willhauck-Fleckenstein M, Pattyn J, Butt J, Tjalma W, Van Ostade X, et al.
J Clin Virol . 2019 May; 117:11-18. PMID: 31129514
Background: Monitoring HPV antibodies non-invasively would be a major advantage for large epidemiological studies and follow-up of vaccinees. Objectives: This study investigated the presence of HPV-specific antibody transudates from systemic...
5.
Basu P, Muwonge R, Bhatla N, Nene B, Joshi S, Esmy P, et al.
Papillomavirus Res . 2019 Feb; 7:75-81. PMID: 30711698
Earlier publication from the ongoing multi-centric study of the International Agency for Research on Cancer to evaluate less than three doses of the quadrivalent Human Papillomavirus (HPV) vaccine in India...
6.
Hulstein S, Matser A, Alberts C, Snijder M, Willhauck-Fleckenstein M, Hufnagel K, et al.
BMC Infect Dis . 2018 Dec; 18(1):612. PMID: 30509189
Background: In the Netherlands, there are strong disparities in Chlamydia trachomatis (CT) prevalence between ethnic groups. The current study aims to identify whether socioeconomic status, sexual risk behavior and sexual...
7.
Hufnagel K, Lueong S, Willhauck-Fleckenstein M, Hotz-Wagenblatt A, Miao B, Bauer A, et al.
Sci Rep . 2018 May; 8(1):7503. PMID: 29760479
Using Chlamydia trachomatis (Ct) as a complex model organism, we describe a method to generate bacterial whole-proteome microarrays using cell-free, on-chip protein expression. Expression constructs were generated by two successive...
8.
Bhatla N, Nene B, Joshi S, Esmy P, Poli U, Joshi G, et al.
Papillomavirus Res . 2018 Mar; 5:163-171. PMID: 29578097
Extending two-dose recommendations of HPV vaccine to girls between 15 and 18 years will reduce program cost and improve compliance. Immunogenicity and vaccine targeted HPV infection outcomes were compared between...
9.
Bassig B, Willhauck-Fleckenstein M, Shu X, Koh W, Gao Y, Purdue M, et al.
Int J Cancer . 2018 Mar; 143(3):570-579. PMID: 29574937
Incidence rates of non-Hodgkin lymphoma (NHL) and distributions of certain viruses differ between East Asian and Western populations. There are limited data on associations between serologic markers of multiple viral...
10.
Butt J, Jenab M, Willhauck-Fleckenstein M, Michel A, Pawlita M, Kyro C, et al.
Int J Cancer . 2018 Jan; 143(2):245-252. PMID: 29377173
The gut microbiome is increasingly implicated in colorectal cancer (CRC) development. A subgroup of patients diagnosed with CRC show high antibody responses to Streptococcus gallolyticus subspecies gallolyticus (SGG). However, it...